Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| ASTH | 8-K | bullish | 6/10 | Astrana Health filed an updated investor presentation via an 8-K (Items 7.01, 9.01) that reaffirms and raises FY2026 Adj | Sep 15, 2026 |
| CLST | 8-K | neutral | 2/10 | Catalyst Bancorp entered into new three-year employment agreements with its COO (Amanda Quebedeaux, $162,500 base salary | Sep 15, 2026 |
| SNUS-PH | 8-K | bullish | 7/10 | Santander Holdings USA, Inc. announced the full redemption of its Fixed-Rate Reset Non-Cumulative Perpetual Preferred St | Sep 15, 2026 |
| PLSE | 8-K | bullish | 6/10 | Pulse Biosciences announced completion of patient enrollment (100 patients, doubled from original 50) in its PRECISE-BTN | Sep 15, 2026 |
| EVMN | 8-K | neutral | 4/10 | Evommune posted an updated corporate presentation on its website via an 8-K (Item 7.01). The presentation highlights Pha | Sep 15, 2026 |
| SRRK | 8-K | neutral | 3/10 | Scholar Rock filed an 8-K to correct an error made during the September 14 investor call announcing FDA approval of ISEM | Sep 15, 2026 |
| BMRN | 8-K | neutral | 4/10 | BioMarin discontinued development of VOXZOGO for Noonan syndrome, citing feasibility and the current treatment landscape | Sep 15, 2026 |
| SMMT | 8-K | bullish | 7/10 | Summit Therapeutics presented updated overall survival (OS) data from the global Phase III HARMONi trial (ivonescimab + | Sep 15, 2026 |
| OMQS | 8-K | bullish | 5/10 | OMNIQ announced the USPTO granted Patent No. 12,633,155 B1 for AI-based vehicle occupancy detection used in HOV lane enf | Sep 15, 2026 |
| SDOT | 8-K | bearish | 8/10 | Sadot Group Inc. filed an 8-K reporting shareholder approval to increase authorized common shares from 12.5M to 1B, enab | Sep 15, 2026 |
| SMG | 8-K | neutral | 5/10 | Scotts Miracle-Gro redeemed all $250M of its 5.250% Senior Notes due 2026, funded via revolver debt and free cash flow, | Sep 15, 2026 |
| GTBP | 8-K | bearish | 7/10 | GT Biopharma entered into a securities purchase agreement to sell up to 41,778 shares of Series M 10% Convertible Prefer | Sep 15, 2026 |
| FEAM | 8-K | bullish | 7/10 | 5E Advanced Materials (FEAM) has been selected as the successful bidder in a Section 363 bankruptcy auction to acquire t | Sep 15, 2026 |
| PDM | 8-K | bullish | 6/10 | Piedmont Realty Trust's operating partnership priced $200M of 2.875% exchangeable senior notes due 2031, with net procee | Sep 15, 2026 |
| VRA | 8-K | mixed | 5/10 | Vera Bradley reported Q2 FY2027 results with net income of $4.5M ($0.15 GAAP diluted EPS) vs a loss of ($4.7M) in the pr | Sep 15, 2026 |
| LIND | 8-K | bullish | 7/10 | Lindblad Expeditions Holdings (LIND) acquired a 60% controlling interest in White Desert (luxury Antarctic expeditions) | Sep 15, 2026 |
| TFC | 8-K | bullish | 6/10 | Truist disclosed an agreement to sell $5.5B of near-prime auto loans (Regional Acceptance Corp) and an illustrative AFS | Sep 15, 2026 |
| BFH | 8-K | bullish | 6/10 | Bread Financial released an August 2026 monthly performance update showing continued improvement in credit quality. The | Sep 15, 2026 |
| QBTS | 8-K | neutral | 2/10 | D-Wave Quantum Inc. announced its platinum sponsorship of Quantum World Congress 2026, where it will showcase results fr | Sep 15, 2026 |
| CNTB | 8-K | mixed | 6/10 | Connect Biopharma reported positive preliminary Phase 2 topline data for rademikibart as an add-on treatment for acute a | Sep 15, 2026 |
| AXON | 424B5, 8-K | mixed | 6/10 | Axon Enterprise is issuing $1 billion of 0% convertible senior notes due 2031 (plus a $150 million over-allotment option | Sep 15, 2026 |
| RCKT | 8-K | bullish | 7/10 | Rocket Pharmaceuticals announced FDA alignment on the path to complete the pivotal Phase 2 trial of RP-A501 for Danon di | Sep 15, 2026 |
| DRVN | 8-K | neutral | 4/10 | Driven Brands announced updated capital allocation priorities including a long-term net leverage target of 2-3x Net Debt | Sep 15, 2026 |
| FPS | 8-K | bullish | 8/10 | Forgent Power Solutions reported a record fiscal Q4 2026, with revenue of $462M (+94% YoY) and Adjusted EPS of $0.25, be | Sep 15, 2026 |
| FBLG | 8-K | neutral | 4/10 | FibroBiologics entered into a securities purchase agreement with its Chief Scientific Officer, Hamid Khoja, to sell 298, | Sep 15, 2026 |
| RIG | 8-K | neutral | 4/10 | Transocean announced a two-well contract for the Deepwater Conqueror drillship in Equatorial Guinea with an undisclosed | Sep 15, 2026 |
| FLEX | 8-K | neutral | 4/10 | Flex announced the appointment of two new independent directors (George R. Oliver and Mark Eubanks) and disclosed the ex | Sep 15, 2026 |
| HBUV | 8-K | neutral | 3/10 | Hubilu Venture Corp, through its subsidiary Elata Investments, LLC, acquired a vacant real property at 5717 4th Ave in L | Sep 15, 2026 |
| PURR | S-1, 8-K | bearish | 6/10 | Hyperliquid Strategies Inc filed a new S-1 resale registration statement to register up to 160,000,000 shares of common | Sep 15, 2026 |
| FATN | 8-K | neutral | 3/10 | FatPipe appointed Kanishka Ragula, age 25, as CFO effective September 11, 2026, replacing Eric Sherb who departed withou | Sep 15, 2026 |